Reckitt Benckiser Group plc (LON:RKT – Get Free Report) hit a new 52-week low on Monday . The stock traded as low as GBX 4,573 and last traded at GBX 4,587, with a volume of 15212000 shares traded. The stock had previously closed at GBX 4,671.
Wall Street Analysts Forecast Growth
RKT has been the topic of several analyst reports. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a GBX 6,200 target price on shares of Reckitt Benckiser Group in a research report on Thursday, April 23rd. Berenberg Bank dropped their target price on Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating on the stock in a research report on Friday, April 24th. Jefferies Financial Group reissued a “hold” rating and set a GBX 5,600 price target on shares of Reckitt Benckiser Group in a report on Tuesday. Deutsche Bank Aktiengesellschaft lowered their price target on Reckitt Benckiser Group from GBX 5,460 to GBX 5,430 and set a “hold” rating on the stock in a report on Tuesday, April 28th. Finally, Citigroup lowered their price target on Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating on the stock in a report on Thursday, April 23rd. Three research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of GBX 6,204.29.
Get Our Latest Analysis on RKT
Reckitt Benckiser Group Price Performance
Reckitt Benckiser Group (LON:RKT – Get Free Report) last issued its quarterly earnings results on Thursday, March 5th. The company reported £122.58 EPS for the quarter. Reckitt Benckiser Group had a return on equity of 38.45% and a net margin of 25.23%. On average, research analysts expect that Reckitt Benckiser Group plc will post 331.2110727 earnings per share for the current fiscal year.
Insiders Place Their Bets
In related news, insider Kris Licht sold 5,435 shares of the firm’s stock in a transaction dated Tuesday, April 28th. The stock was sold at an average price of GBX 4,753, for a total transaction of £258,325.55. 0.44% of the stock is owned by corporate insiders.
About Reckitt Benckiser Group
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Featured Stories
- Five stocks we like better than Reckitt Benckiser Group
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
